The Canadian cannabis sector has roared higher in recent weeks. Expectations about potential legalization in the U.S. have driven valuations in this sector to fresh 52-week highs recently. Investors need to be wary of this rapid sector-wide increase. Indeed, picking and choosing specific cannabis stocks is the only way to go. Accordingly, I’d recommend investors should consider Curaleaf (TSXV:CURA) as the…
Read MoreAuthor: The Motley Fool
Did You Know Shopify Is Fighting Climate Change?
Environmental, social, and governance investing, or ESG for short, has been picking up a lot of traction over the past few years. This has been due, in large part, to a bigger focus on sustainability in society. As such, many companies have been releasing ESG statements and investment funds have even been offering ESG ETFs to retail investors. Shopify (TSX:SHOP)(NYSE:SHOP)…
Read MoreWhy Hexo (TSX:HEXO) Stock Will Likely Double Again in 2021
In the Canadian cannabis sector, one of my top picks for some time has been Hexo (TSX:HEXO)(NYSE:HEXO). My conviction level on this cannabis player relative to its peers hasn’t shifted of late. I think Hexo is a stock that has had a rough go of it in 2020 but is turning things around in the right direction. I think this stock…
Read MoreCannabis Stocks: A Parabolic Move Is Underway
Investors in Canada’s nascent cannabis industry have had a volatile go of it in recent years. The speculative nature of the investor base supporting this sector has driven a lot of this volatility. Accordingly, it’s understandable that an outsized level of volatility could persist for some time in this sector. That said, I think this volatility could be aimed more…
Read MorePAOG Publishes 2021 Cannabis Biopharmaceutical Strategic Outlook
Sandusky, Ohio–(Newsfile Corp. – January 14, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today published a management outlook for 2021 on the company’s strategy to develop and monetize the cannabis assets acquired last year. The strategic outlook is included in its entirety below:PAOG 2021 Cannabis Biopharmaceutical Strategic OutlookPAOG is a longtime participant in the cannabis sector working on initiatives…
Read MorePAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update Tomorrow
Sandusky, Ohio–(Newsfile Corp. – January 13, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today announced the upcoming update covering the company’s 2021 cannabis pharmaceutical and nutraceutical development outlook scheduled for tomorrow, Thursday Jan 14th, 2021, will include an update on the planned PAOG stock dividend to shareholders of Puration, Inc. (OTC Pink: PURA) in conjunction with PAOG’s acquisition of…
Read MorePAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021
Sandusky, Ohio–(Newsfile Corp. – January 12, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today confirmed an update covering the company’s 2021 cannabis pharmaceutical and nutraceutical development outlook is scheduled this Thursday Jan 14th, 2021.In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC Pink: PURA) and RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis…
Read MoreCanadian Stocks to Buy: This Cannabis Stock Is Poised to Soar in 2021!
The fact that Curaleaf (TSXV:CURA) is listed on the Canadian Venture exchange means it’s perhaps less known than some of its Canadian counterparts. That said, I think this stock provides excellent leverage to the cannabis trade as it pertains to the U.S. election results. Potential legalization could help this stock skyrocket relative to its peers in the years to come. The…
Read MorePAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021
Sandusky, Ohio–(Newsfile Corp. – January 11, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today announced an update covering the company’s 2021 cannabis pharmaceutical and nutraceutical development outlook is scheduled this Thursday Jan 14th, 2021. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC Pink: PURA) and RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a…
Read MorePAOG Confirms Q4 2020 Revenue from Cannabis Asset Acquisition
Sandusky, Ohio–(Newsfile Corp. – January 8, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today confirmed that the Company expects to realize and report in Q4 2020 the first revenue from assets acquired in the course of 2020.In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC Pink: PURA) and RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx…
Read More